About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

National Survey on Infiltrative Breast Cancer

NCT00696527·107 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Women\> or = 18 years old
Women with newly diagnosis of infiltrative breast cancer
Agree to take part in this study

You may not be if

Women with other malignant tumor (except in situ cervical carcinoma or treated basal cell carcinoma)
Women with in situ ductal carcinoma or in situ lobular carcinoma

The record

StatusCompleted

PhaseNo phase

Taking part1,500

StartedJun 2007

UpdatedDec 10, 2010

Conditions

Infiltrative Breast Cancer

Where107

Research Site
Aix-en-Provence, France
Research Site
Alès, France
Research Site
Amilly, France

Clareo Health | National Survey on Infiltrative Breast Cancer